\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ significant\\ for\\ valgus\\ deformity\\ of\\ bilateral\\ knees\\,\\ right\\ \\>\\ left\\.\ \(0\)\
\-\ labs\\ significant\\ for\ \(0\)\
\-\ \\ 25\\ hydroxy\\ vitamin\\ d\\ 9\\ \\(less\\ than\\ 20\\ considered\\ abnormal\\)\ \(0\)\
\-\ \\ 1\\,25\\ dihydroxy\\ vitamin\\ d3\\ 20\\ \\(less\\ than\\ 27\\ abnormal\\)\ \(0\)\
\-\ \\ alkaline\\ phosphate\\ 2497\\ \\(normal\\ range\\ 38\\-126\\)\ \(1\)\
\-\ \\ pth\\ 404\\ \\(normal\\ range\\ 7\\-62\\)\ \(0\)\
\-\ the\\ patient\\ was\\ given\\ high\\ dose\\ vit\\ d\\ therapy\\ with\\ 600\\,000\\ iu\\ vit\\ d\\ po\\ in\\ divided\\ doses\\ as\\ an\\ inpatient\\ and\\ then\\ 400\\ iu\\ vit\\ d\\ po\\ qd\\.\\ \\ the\\ patient\\ was\\ given\\ 1000\\ mg\\ of\\ calcium\\ qd\\ as\\ hypocalcemia\\ can\\ be\\ an\\ adverse\\ reaction\\ of\\ supplemental\\ vit\\ d\\.\\ \\ further\\ follow\\ up\\ is\\ unknown\\.\ \(0\)\
\-\ please\\ see\\ image\\ captions\\ for\\ specific\\ findings\\ in\\ case\\ submitted\\.\\ \\ general\\ findings\\ include\\:\\ demineralization\\,\\ widening\\ of\\ the\\ epiphyseal\\ plates\\,\\ metaphyseal\\ cupping\\,\\ irregularity\\ and\\ indistinctness\\ of\\ the\\ provisional\\ zone\\ of\\ calcification\\,\\ poorly\\ ossified\\ epiphyses\\ with\\ indistinct\\ borders\\,\\ coarsened\\ trabeculae\\,\\ unsharp\\ border\\ of\\ the\\ inferior\\ scapular\\ angle\\ and\\ iliac\\ crest\\,\\ pathologic\\ fractures\\,\\ skeletal\\ deformities\\.\ \(0\)\
\-\ rickets\\ \\(vitamin\\ d\\ dependent\\)\ \(0\)\
\-\ abnormal\\ vit\\ d\\ metabolism\\ secondary\\ to\\:\ \(0\)\
\-\ vit\\ d\\ deficiency\\:\\ malabsorption\\,\\ inadequate\\ dietary\\ intake\\,\\ inadequate\\ sunlight\ \(0\)\
\-\ hepatic\\ origin\\:\\ anticonvulsant\\ therapy\\ \\(increased\\ hepatic\\ metabolism\\)\\,\\ liver\\ disease\\ \\(failure\\ of\\ 25\\ hydroxylation\\)\ \(1\)\
\-\ renal\\ origin\\:\\ vit\\ d\\ dependent\\ rickets\\,\\ parathyroid\\ disorders\\ \\(hypo\\,\\ hyper\\,\\ pseudohypo\\)\\,\\ maternal\\ renal\\ insufficiency\\ as\\ a\\ cause\\ of\\ congenital\\ rickets\\ and\\ secondary\\ hyperparathyroidism\\.\ \(0\)\
\-\ phosphate\\ loss\\ due\\ to\\ renal\\ tubular\\ disorders\\:\ \(0\)\
\-\ vit\\ d\\ resistant\\ rickets\\:\\ x\\-linked\\ hypophosphatemia\ \(0\)\
\-\ fanconi\\ syndrome\ \(0\)\
\-\ renal\\ tubular\\ acidosis\ \(5\)\
\-\ tumor\\ related\ \(0\)\
\-\ hemangiomas\\ of\\ the\\ bone\\ or\\ soft\\ tissue\ \(2\)\
\-\ metastatic\\ neuroblastoma\ \(2\)\
\-\ dietary\\ calcium\\ deficiency\ \(0\)\
\-\ 4\\ yo\\ female\\ with\\ inherited\\ vitamin\\ d\\-dependent\\ rickets\\.\\ \\ the\\ patients\\ mother\\ has\\ a\\ documented\\ history\\ of\\ rickets\\ as\\ well\\.\\ \\ the\\ patient\\ was\\ diagnosed\\ at\\ 30\\ months\\ of\\ age\\ after\\ presenting\\ to\\ her\\ primary\\ care\\ md\\ with\\ a\\ right\\ leg\\ limp\\.\\ \\ orthopedic\\ exam\\ and\\ subsequent\\ radiographs\\ and\\ labs\\ were\\ consistent\\ with\\ vitamin\\ d\\ dependent\\ rickets\\.\\ \\ the\\ patient\\ was\\ then\\ begun\\ on\\ supplemental\\ vit\\ d\\.\\ \\ however\\,\\ the\\ patient\\ had\\ poor\\ compliance\\ with\\ the\\ medication\\ and\\ follow\\ up\\.\\ \\ she\\ now\\ presented\\ because\\ her\\ father\\ was\\ concerned\\ she\\ may\\ need\\ surgery\\ for\\ her\\ worsening\\ valgus\\ deformity\\.\ \(0\)\
\-\ per\\ the\\ patients\\ record\\ she\\ had\\ the\\ diagnosis\\ of\\ hereditary\\ vit\\ d\\ dependent\\ rickets\\.\\ \\ however\\,\\ that\\ may\\ be\\ a\\ misdiagnosis\\ as\\ hereditary\\ vit\\ d\\ dependent\\ rickets\\ is\\ a\\ rare\\,\\ autosomal\\ recessive\\ disorder\\ that\\ typically\\ presents\\ as\\ early\\ as\\ 3\\ months\\ of\\ age\\,\\ in\\ contrast\\ to\\ nutritional\\ rickets\\,\\ with\\ most\\ patients\\ syptomatic\\ by\\ 1\\ year\\ of\\ age\\.\\ \\ furthermore\\,\\ rachitic\\ changes\\ can\\ be\\ severe\\ and\\ rapidly\\ progressive\\ with\\ pathologic\\ fractures\\.\\ \\ hypocalcemia\\ is\\ the\\ primary\\ rachitic\\ factor\\ from\\ decreased\\ intestinal\\ absorption\\ and\\ secondary\\ hypoparathyroidism\\ follows\\.\\ \\ this\\ patient\\ does\\ have\\ hypoparathyroidism\\,\\ as\\ evident\\ by\\ her\\ labs\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ vit\\:\\ 0\\.127740649740084\ \(0\)\
\-\ rickets\\:\\ 0\\.11118866155953207\ \(0\)\
\-\ d\\:\\ 0\\.105660533860313\ \(0\)\
\-\ vitamin\\:\\ 0\\.051976537087275176\ \(0\)\
\-\ dependent\\:\\ 0\\.0476324979811522\ \(0\)\
\-\ \\-vit\\:\\ 0\\.03642776208250619\ \(0\)\
\-\ iu\\:\\ 0\\.0318880418813983\ \(0\)\
\-\ rachitic\\:\\ 0\\.0318880418813983\ \(0\)\
\-\ hypocalcemia\\:\\ 0\\.030699272986969454\ \(0\)\
\-\ hypoparathyroidism\\:\\ 0\\.029777192196414868\ \(0\)\
\-\ \\-renal\\:\\ 0\\.027348321680290406\ \(0\)\
\-\ phosphate\\:\\ 0\\.02651910393044681\ \(0\)\
\-\ supplemental\\:\\ 0\\.02651910393044681\ \(0\)\
\-\ dietary\\:\\ 0\\.02365485938267844\ \(0\)\
\-\ inadequate\\:\\ 0\\.023471174413377476\ \(0\)\
\-\ qd\\:\\ 0\\.02329530823809319\ \(0\)\
\-\ metabolism\\:\\ 0\\.022964553247706677\ \(0\)\
\-\ valgus\\:\\ 0\\.022658321957815267\ \(0\)\
\-\ as\\:\\ 0\\.0213649174527955\ \(0\)\
\-\ her\\:\\ 0\\.021234807094916822\ \(0\)\
\-\ d\\.\\:\\ 0\\.020982846304475743\ \(0\)\
\-\ hereditary\\:\\ 0\\.020262377762555173\ \(0\)\
\-\ po\\:\\ 0\\.02018054872414121\ \(0\)\
\-\ deficiency\\:\\ 0\\.019052999192460878\ \(0\)\
\-\ labs\\:\\ 0\\.018421326489267385\ \(0\)\
\-\ dihydroxy\\:\\ 0\\.018213881041253096\ \(0\)\
\-\ 2497\\:\\ 0\\.018213881041253096\ \(0\)\
\-\ unsharp\\:\\ 0\\.018213881041253096\ \(0\)\
\-\ \\-fanconi\\:\\ 0\\.018213881041253096\ \(0\)\
\-\ d\\-dependent\\:\\ 0\\.018213881041253096\ \(0\)\
\-\ syptomatic\\:\\ 0\\.018213881041253096\ \(0\)\
\-\ calcium\\:\\ 0\\.017275989403871334\ \(0\)\
\-\ disorders\\:\\ 0\\.016893101674603957\ \(0\)\
\-\ hydroxy\\:\\ 0\\.016781758767368912\ \(0\)\
\-\ 404\\:\\ 0\\.016781758767368912\ \(0\)\
\-\ 7\\-62\\:\\ 0\\.016781758767368912\ \(0\)\
\-\ hydroxylation\\:\\ 0\\.016781758767368912\ \(0\)\
\-\ pseudohypo\\:\\ 0\\.016781758767368912\ \(0\)\
\-\ \\-hemangiomas\\:\\ 0\\.016781758767368912\ \(0\)\
\-\ tubular\\:\\ 0\\.016443126103367855\ \(0\)\
\-\ \\:\\:\\ 0\\.01634694981804681\ \(0\)\
\-\ origin\\:\\ 0\\.016188754644692507\ \(0\)\
\-\ age\\:\\ 0\\.016121344993043223\ \(0\)\
\-\ d3\\:\\ 0\\.01594402094069915\ \(0\)\
\-\ sunlight\\:\\ 0\\.01594402094069915\ \(0\)\
\-\ \\-hepatic\\:\\ 0\\.01594402094069915\ \(0\)\
\-\ pathologic\\:\\ 0\\.015455969457573023\ \(0\)\
\-\ 1\\,25\\:\\ 0\\.015349636493484727\ \(0\)\
\-\ 600\\,000\\:\\ 0\\.015349636493484727\ \(0\)\
\-\ misdiagnosis\\:\\ 0\\.015349636493484727\ \(0\)\
\-\ deformity\\:\\ 0\\.015205454491389407\ \(0\)\
\-\ abnormal\\:\\ 0\\.015105943638315567\ \(0\)\
\-\ hypophosphatemia\\:\\ 0\\.014888596098207434\ \(0\)\
\-\ she\\:\\ 0\\.01486850914124487\ \(0\)\
\-\ secondary\\:\\ 0\\.014808036982492608\ \(0\)\
\-\ indistinctness\\:\\ 0\\.014511898666814965\ \(0\)\
\-\ 25\\:\\ 0\\.01427366222420278\ \(0\)\
\-\ range\\:\\ 0\\.014215867835877409\ \(0\)\
\-\ coarsened\\:\\ 0\\.013917514219600541\ \(0\)\
\-\ compliance\\:\\ 0\\.013917514219600541\ \(0\)\
\-\ patients\\:\\ 0\\.013708107020863797\ \(0\)\
\-\ captions\\:\\ 0\\.013674160840145203\ \(0\)\
\-\ provisional\\:\\ 0\\.013674160840145203\ \(0\)\
\-\ hypo\\:\\ 0\\.013674160840145203\ \(0\)\
\-\ x\\-linked\\:\\ 0\\.013674160840145203\ \(0\)\
\-\ record\\:\\ 0\\.013674160840145203\ \(0\)\
\-\ 38\\-126\\:\\ 0\\.013456473824323249\ \(0\)\
\-\ malabsorption\\:\\ 0\\.013456473824323249\ \(0\)\
\-\ anticonvulsant\\:\\ 0\\.013456473824323249\ \(0\)\
\-\ nutritional\\:\\ 0\\.013456473824323249\ \(0\)\
\-\ fractures\\:\\ 0\\.013371027264381306\ \(0\)\
\-\ demineralization\\:\\ 0\\.013259551965223404\ \(0\)\
\-\ absorption\\:\\ 0\\.013079776392930781\ \(0\)\
\-\ 400\\:\\ 0\\.012914398897737524\ \(0\)\
\-\ inherited\\:\\ 0\\.012914398897737524\ \(0\)\
\-\ begun\\:\\ 0\\.012914398897737524\ \(0\)\
\-\ \\,\\:\\ 0\\.012864321295242996\ \(0\)\
\-\ adverse\\:\\ 0\\.012761283252791817\ \(0\)\
\-\ 20\\:\\ 0\\.012696343951062049\ \(0\)\
\-\ doses\\:\\ 0\\.012618735997653488\ \(0\)\
\-\ 1000\\:\\ 0\\.012618735997653488\ \(0\)\
\-\ cupping\\:\\ 0\\.012618735997653488\ \(0\)\
\-\ epiphyses\\:\\ 0\\.012618735997653488\ \(0\)\
\-\ scapular\\:\\ 0\\.012618735997653488\ \(0\)\
\-\ crest\\:\\ 0\\.012618735997653488\ \(0\)\
\-\ hyper\\:\\ 0\\.012618735997653488\ \(0\)\
\-\ \\-metastatic\\:\\ 0\\.012618735997653488\ \(0\)\
\-\ then\\:\\ 0\\.012565978836454918\ \(0\)\
\-\ trabeculae\\:\\ 0\\.012242038566261021\ \(0\)\
\-\ given\\:\\ 0\\.012105018150893978\ \(0\)\
\-\ pth\\:\\ 0\\.012024351550439065\ \(0\)\
\-\ less\\:\\ 0\\.01195842976992844\ \(0\)\
\-\ \\(\\:\\ 0\\.011939863243700175\ \(0\)\
\-\ resistant\\:\\ 0\\.011923545426122055\ \(0\)\
\-\ plates\\:\\ 0\\.01182742969133922\ \(0\)\
\-\ ossified\\:\\ 0\\.01182742969133922\ \(0\)\
\-\ concerned\\:\\ 0\\.01182742969133922\ \(0\)\
\-\ \\)\\:\\ 0\\.01179401143988934\ \(0\)\
\-\ limp\\:\\ 0\\.011735587206688738\ \(0\)\
\-\ recessive\\:\\ 0\\.011735587206688738\ \(0\)\
\-\ indistinct\\:\\ 0\\.011563311155161772\ \(0\)\
\-\ acidosis\\:\\ 0\\.011404300739591259\ \(0\)\
\-\ alkaline\\:\\ 0\\.011256658252024843\ \(0\)\
\-\ follow\\:\\ 0\\.011219832528704274\ \(0\)\
\-\ parathyroid\\:\\ 0\\.011186613723769303\ \(0\)\
\-\ divided\\:\\ 0\\.011118866155953207\ \(0\)\
\-\ epiphyseal\\:\\ 0\\.011118866155953207\ \(0\)\
\-\ maternal\\:\\ 0\\.011118866155953207\ \(0\)\
\-\ intake\\:\\ 0\\.01086812058363034\ \(0\)\
\-\ furthermore\\:\\ 0\\.010809916292376836\ \(0\)\
\-\ inpatient\\:\\ 0\\.010644538797183578\ \(0\)\
\-\ patient\\:\\ 0\\.010618908234500677\ \(0\)\
\-\ renal\\:\\ 0\\.01060940309693417\ \(0\)\
\-\ documented\\:\\ 0\\.01059222927655488\ \(0\)\
\-\ metaphyseal\\:\\ 0\\.010541211481946675\ \(0\)\
\-\ father\\:\\ 0\\.010541211481946675\ \(0\)\
\-\ primary\\:\\ 0\\.010460265549155771\ \(0\)\
\-\ submitted\\:\\ 0\\.01044280642205152\ \(0\)\
\-\ knees\\:\\ 0\\.010259030624496776\ \(0\)\
\-\ autosomal\\:\\ 0\\.010215531845162412\ \(0\)\
\-\ was\\:\\ 0\\.010209478535265359\ \(0\)\
\-\ intestinal\\:\\ 0\\.010010798575236316\ \(0\)\
\-\ deformities\\:\\ 0\\.009972178465707074\ \(0\)\
\-\ however\\:\\ 0\\.00983209940329368\ \(0\)\
\-\ borders\\:\\ 0\\.00982453597814066\ \(0\)\
\-\ rapidly\\:\\ 0\\.009789216900952023\ \(0\)\
\-\ mg\\:\\ 0\\.009686743882069023\ \(0\)\
\-\ months\\:\\ 0\\.009644385515248212\ \(0\)\
\-\ follows\\:\\ 0\\.00949588991485618\ \(0\)\
\-\ significant\\:\\ 0\\.009495236161381088\ \(0\)\
\-\ up\\:\\ 0\\.009495236161381088\ \(0\)\
\-\ therapy\\:\\ 0\\.00944066444727526\ \(0\)\
\-\ irregularity\\:\\ 0\\.009435998309746155\ \(0\)\
\-\ zone\\:\\ 0\\.009377794018492652\ \(0\)\
\-\ insufficiency\\:\\ 0\\.009377794018492652\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.00926608488363671\ \(0\)\
\-\ than\\:\\ 0\\.009252267995530057\ \(0\)\
\-\ dose\\:\\ 0\\.00923907645064631\ \(0\)\
\-\ factor\\:\\ 0\\.009010684148167336\ \(0\)\
\-\ widening\\:\\ 0\\.008893923383160432\ \(0\)\
\-\ medication\\:\\ 0\\.008893923383160432\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.008826908350612592\ \(0\)\
\-\ iliac\\:\\ 0\\.008805044488359417\ \(0\)\
\-\ need\\:\\ 0\\.008805044488359417\ \(0\)\
\-\ skeletal\\:\\ 0\\.008719831764115513\ \(0\)\
\-\ md\\:\\ 0\\.008719831764115513\ \(0\)\
\-\ poorly\\:\\ 0\\.008618032076084971\ \(0\)\
\-\ orthopedic\\:\\ 0\\.008428347056966948\ \(0\)\
\-\ border\\:\\ 0\\.008410302263643074\ \(0\)\
\-\ angle\\:\\ 0\\.008288217725688517\ \(0\)\
\-\ 27\\:\\ 0\\.008189025124063803\ \(0\)\
\-\ be\\:\\ 0\\.008167913574445842\ \(0\)\
\-\ evident\\:\\ 0\\.008079015796545597\ \(0\)\
\-\ mother\\:\\ 0\\.008063767640971997\ \(0\)\
\-\ reaction\\:\\ 0\\.00801868696453679\ \(0\)\
\-\ can\\:\\ 0\\.008009183274665576\ \(0\)\
\-\ poor\\:\\ 0\\.007945671744608467\ \(0\)\
\-\ pe\\:\\ 0\\.007931373308979181\ \(0\)\
\-\ disorder\\:\\ 0\\.007931373308979181\ \(0\)\
\-\ please\\:\\ 0\\.007833962609752524\ \(0\)\
\-\ may\\:\\ 0\\.007745158549165801\ \(0\)\
\-\ per\\:\\ 0\\.007727984728786511\ \(0\)\
\-\ had\\:\\ 0\\.0076192141290938355\ \(0\)\
\-\ findings\\:\\ 0\\.007515855106570081\ \(0\)\
\-\ general\\:\\ 0\\.007439220385036183\ \(0\)\
\-\ hepatic\\:\\ 0\\.007372922214475232\ \(0\)\
\-\ 9\\:\\ 0\\.0072981708579101445\ \(0\)\
\-\ specific\\:\\ 0\\.0072981708579101445\ \(0\)\
\-\ related\\:\\ 0\\.007287709490231329\ \(0\)\
\-\ presenting\\:\\ 0\\.007195867005580846\ \(0\)\
\-\ considered\\:\\ 0\\.0071271537374889395\ \(0\)\
\-\ progressive\\:\\ 0\\.0069781799897588905\ \(0\)\
\-\ worsening\\:\\ 0\\.0069514048975223095\ \(0\)\
\-\ leg\\:\\ 0\\.006942556422745448\ \(0\)\
\-\ failure\\:\\ 0\\.006916236121552411\ \(0\)\
\-\ unknown\\:\\ 0\\.006890246902116749\ \(0\)\
\-\ subsequent\\:\\ 0\\.006873100615309528\ \(0\)\
\-\ rare\\:\\ 0\\.006856095451804331\ \(0\)\
\-\ 30\\:\\ 0\\.006789440777799742\ \(0\)\
\-\ diagnosed\\:\\ 0\\.006492138753708689\ \(0\)\
\-\ congenital\\:\\ 0\\.006456940019922392\ \(0\)\
\-\ early\\:\\ 0\\.006456940019922392\ \(0\)\
\-\ calcification\\:\\ 0\\.006408647972018862\ \(0\)\
\-\ care\\:\\ 0\\.00636813460138172\ \(0\)\
\-\ typically\\:\\ 0\\.006232284647739612\ \(0\)\
\-\ because\\:\\ 0\\.006176690736748033\ \(0\)\
\-\ that\\:\\ 0\\.00609909391966456\ \(0\)\
\-\ liver\\:\\ 0\\.006087234526513892\ \(0\)\
\-\ now\\:\\ 0\\.006035362788639768\ \(0\)\
\-\ for\\:\\ 0\\.006025687178865415\ \(0\)\
\-\ does\\:\\ 0\\.0060240104760000135\ \(0\)\
\-\ inferior\\:\\ 0\\.005990323060659221\ \(0\)\
\-\ cause\\:\\ 0\\.005973683112710674\ \(0\)\
\-\ by\\:\\ 0\\.005879631831590392\ \(0\)\
\-\ \\>\\:\\ 0\\.00586604858402596\ \(0\)\
\-\ further\\:\\ 0\\.005614554011984005\ \(0\)\
\-\ radiographs\\:\\ 0\\.005591468680169696\ \(0\)\
\-\ normal\\:\\ 0\\.005535588655368186\ \(0\)\
\-\ image\\:\\ 0\\.005514853649375208\ \(0\)\
\-\ severe\\:\\ 0\\.005432458264599182\ \(0\)\
\-\ yo\\:\\ 0\\.005312709758890004\ \(0\)\
\-\ see\\:\\ 0\\.0052690438248528685\ \(0\)\
\-\ decreased\\:\\ 0\\.005249496699844132\ \(0\)\
\-\ loss\\:\\ 0\\.005124925976174462\ \(0\)\
\-\ changes\\:\\ 0\\.005060016479824505\ \(0\)\
\-\ syndrome\\:\\ 0\\.0050493937535839705\ \(0\)\
\-\ include\\:\\ 0\\.004952796462872494\ \(0\)\
\-\ 4\\:\\ 0\\.004919363440452573\ \(0\)\
\-\ an\\:\\ 0\\.004882912662333595\ \(0\)\
\-\ high\\:\\ 0\\.004831706737762016\ \(0\)\
\-\ presented\\:\\ 0\\.004812722386409936\ \(0\)\
\-\ due\\:\\ 0\\.0047113164317207435\ \(0\)\
\-\ bone\\:\\ 0\\.00438726173855345\ \(0\)\
\-\ consistent\\:\\ 0\\.004329128654609924\ \(0\)\
\-\ increased\\:\\ 0\\.004319183433470363\ \(0\)\
\-\ soft\\:\\ 0\\.004299435462796591\ \(0\)\
\-\ surgery\\:\\ 0\\.0042871881495047\ \(0\)\
\-\ bilateral\\:\\ 0\\.00428474737461662\ \(0\)\
\-\ 1\\:\\ 0\\.004201087537106832\ \(0\)\
\-\ tissue\\:\\ 0\\.004184754521596268\ \(0\)\
\-\ 3\\:\\ 0\\.0041342469560052475\ \(0\)\
\-\ tumor\\:\\ 0\\.004116182441344651\ \(0\)\
\-\ a\\:\\ 0\\.00409710539068803\ \(0\)\
\-\ most\\:\\ 0\\.00407610566472743\ \(0\)\
\-\ diagnosis\\:\\ 0\\.004054172171033926\ \(0\)\
\-\ were\\:\\ 0\\.00400885606754116\ \(0\)\
\-\ the\\:\\ 0\\.0039989462517577715\ \(0\)\
\-\ well\\:\\ 0\\.003993968911092254\ \(0\)\
\-\ contrast\\:\\ 0\\.003952015881834515\ \(0\)\
\-\ exam\\:\\ 0\\.0038785825205568973\ \(0\)\
\-\ case\\:\\ 0\\.0038626124646017994\ \(0\)\
\-\ have\\:\\ 0\\.0038232191701758097\ \(0\)\
\-\ right\\:\\ 0\\.003725750864092631\ \(0\)\
\-\ after\\:\\ 0\\.0036528950467132285\ \(0\)\
\-\ female\\:\\ 0\\.003629669982330235\ \(0\)\
\-\ of\\:\\ 0\\.0036106549834087325\ \(0\)\
\-\ presents\\:\\ 0\\.003606703089892409\ \(0\)\
\-\ to\\:\\ 0\\.0035294884995288123\ \(0\)\
\-\ is\\:\\ 0\\.003485273419740035\ \(0\)\
\-\ and\\:\\ 0\\.003347274899979269\ \(0\)\
\-\ has\\:\\ 0\\.0033154958068063595\ \(0\)\
\-\ disease\\:\\ 0\\.0028858213661481493\ \(0\)\
\-\ from\\:\\ 0\\.002616602713128538\ \(0\)\
\-\ in\\:\\ 0\\.0026119663025222415\ \(0\)\
\-\ history\\:\\ 0\\.0024384597886509987\ \(0\)\
\-\ at\\:\\ 0\\.0023920726298174238\ \(0\)\
\-\ or\\:\\ 0\\.002069261878024189\ \(0\)\
\-\ this\\:\\ 0\\.0019858206886655644\ \(0\)\
\-\ left\\:\\ 0\\.001975424110068006\ \(0\)\
\-\ year\\:\\ 0\\.001975424110068006\ \(0\)\
\-\ with\\:\\ 0\\.0019339533237998305\ \(0\)\
\-\ on\\:\\ 0\\.0014956425875318762\ \(0\)\
\-\ \\.\\:\\ 0\\.0012468845323448073\ \(0\)\
